(LOW) Lowe's Companies - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5486611073
Stock:
Total Rating 45
Risk 70
Buy Signal -0.53
| Risk 5d forecast | |
|---|---|
| Volatility | 27.0% |
| Relative Tail Risk | -4.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.34 |
| Alpha | -3.82 |
| Character TTM | |
|---|---|
| Beta | 0.709 |
| Beta Downside | 0.135 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.83% |
| CAGR/Max DD | 0.49 |
EPS (Earnings per Share)
Revenue
Description: LOW Lowe's Companies
Lowe's Companies, Inc., together with its subsidiaries, operates as a home improvement retailer in the United States. It provides a line of products for construction, maintenance, repair, remodeling, and decorating. The company also offers home improvement products, such as appliances, seasonal and outdoor living, lumber, lawn and garden, kitchens and bath, hardware, building materials, millwork, paint, rough plumbing, tools, electrical, flooring, and décor. In addition, it offers installation services through independent contractors in various product categories; and extended protection plans and repair services. The company sells its national brand-name merchandise and private brand products to professional customers, individual homeowners, and renters. The company also sells its products through Lowes.com website, as well as through mobile applications. Further, it provides design, distribution, and installation services for interior surface finishes to home builders and property managers. Lowe's Companies, Inc. was founded in 1921 and is based in Mooresville, North Carolina.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 6.65b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA -3.14 > 1.0 |
| NWC/Revenue: 1.73% < 20% (prev 1.91%; Δ -0.18% < -1%) |
| CFO/TA 0.18 > 3% & CFO 9.86b > Net Income 6.65b |
| Net Debt (6.21b) to EBITDA (11.97b): 0.52 < 3 |
| Current Ratio: 1.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (560.0m) vs 12m ago -0.53% < -2% |
| Gross Margin: 33.48% > 18% (prev 0.31%; Δ 3316 % > 0.5%) |
| Asset Turnover: 174.8% > 50% (prev 187.7%; Δ -12.91% > 0%) |
| Interest Coverage Ratio: 8.90 > 6 (EBITDA TTM 11.97b / Interest Expense TTM 1.11b) |
Altman Z'' 0.70
| A: 0.03 (Total Current Assets 20.95b - Total Current Liabilities 19.46b) / Total Assets 54.14b |
| B: -0.20 (Retained Earnings -10.84b / Total Assets 54.14b) |
| C: 0.20 (EBIT TTM 9.85b / Avg Total Assets 49.36b) |
| D: -0.16 (Book Value of Equity -10.29b / Total Liabilities 64.06b) |
| Altman-Z'' Score: 0.70 = B |
Beneish M
| DSRI: none (Receivables 1.09b/none, Revenue 86.29b/83.67b) |
| GMI: 0.93 (GM 33.48% / 31.25%) |
| AQI: 3.06 (AQ_t 0.19 / AQ_t-1 0.06) |
| SGI: 1.03 (Revenue 86.29b / 83.67b) |
| TATA: -0.06 (NI 6.65b - CFO 9.86b) / TA 54.14b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of LOW shares?
As of March 02, 2026, the stock is trading at USD 264.57 with a total of 3,251,435 shares traded.
Over the past week, the price has changed by -3.57%, over one month by -1.67%, over three months by +7.86% and over the past year by +9.64%.
Over the past week, the price has changed by -3.57%, over one month by -1.67%, over three months by +7.86% and over the past year by +9.64%.
Is LOW a buy, sell or hold?
Lowe's Companies has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy LOW.
- StrongBuy: 18
- Buy: 4
- Hold: 13
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the LOW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 287.5 | 8.7% |
| Analysts Target Price | 287.5 | 8.7% |
LOW Fundamental Data Overview February 28, 2026
P/E Trailing = 21.8866
P/E Forward = 18.5185
P/S = 1.7188
P/B = 321.8177
P/EG = 2.1776
Revenue TTM = 86.29b USD
EBIT TTM = 9.85b USD
EBITDA TTM = 11.97b USD
Long Term Debt = 37.50b USD (from longTermDebt, two quarters ago)
Short Term Debt = 3.14b USD (from shortTermDebt, last quarter)
Debt = 7.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.21b USD (from netDebt column, last quarter)
Enterprise Value = 154.14b USD (148.31b + Debt 7.19b - CCE 1.35b)
Interest Coverage Ratio = 8.90 (Ebit TTM 9.85b / Interest Expense TTM 1.11b)
EV/FCF = 20.15x (Enterprise Value 154.14b / FCF TTM 7.65b)
FCF Yield = 4.96% (FCF TTM 7.65b / Enterprise Value 154.14b)
FCF Margin = 8.87% (FCF TTM 7.65b / Revenue TTM 86.29b)
Net Margin = 7.71% (Net Income TTM 6.65b / Revenue TTM 86.29b)
Gross Margin = 33.48% ((Revenue TTM 86.29b - Cost of Revenue TTM 57.40b) / Revenue TTM)
Gross Margin QoQ = 39.16% (prev 31.91%)
Tobins Q-Ratio = 2.85 (Enterprise Value 154.14b / Total Assets 54.14b)
Interest Expense / Debt = 5.45% (Interest Expense 392.0m / Debt 7.19b)
Taxrate = 23.45% (306.0m / 1.30b)
NOPAT = 7.54b (EBIT 9.85b * (1 - 23.45%))
Current Ratio = 1.08 (Total Current Assets 20.95b / Total Current Liabilities 19.46b)
Debt / Equity = -0.72 (negative equity) (Debt 7.19b / totalStockholderEquity, last quarter -9.92b)
Debt / EBITDA = 0.52 (Net Debt 6.21b / EBITDA 11.97b)
Debt / FCF = 0.81 (Net Debt 6.21b / FCF TTM 7.65b)
Total Stockholder Equity = -11.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.48% (Net Income 6.65b / Total Assets 54.14b)
RoE = -59.21% (negative equity) (Net Income TTM 6.65b / Total Stockholder Equity -11.24b)
RoCE = 37.53% (EBIT 9.85b / Capital Employed (Equity -11.24b + L.T.Debt 37.50b))
RoIC = 30.44% (NOPAT 7.54b / Invested Capital 24.78b)
WACC = 8.33% (E(148.31b)/V(155.50b) * Re(8.53%) + D(7.19b)/V(155.50b) * Rd(5.45%) * (1-Tc(0.23)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.53%
[DCF] Terminal Value 76.35% ; FCFF base≈7.67b ; Y1≈7.41b ; Y5≈7.32b
[DCF] Fair Price = 206.0 (EV 121.78b - Net Debt 6.21b = Equity 115.58b / Shares 561.0m; r=8.33% [WACC]; 5y FCF grow -4.62% → 2.90% )
EPS Correlation: -31.47 | EPS CAGR: -14.16% | SUE: -1.45 | # QB: 0
Revenue Correlation: -52.18 | Revenue CAGR: -3.64% | SUE: 1.14 | # QB: 1
EPS next Quarter (2026-04-30): EPS=2.99 | Chg7d=-0.093 | Chg30d=-0.087 | Revisions Net=-1 | Analysts=26
EPS current Year (2027-01-31): EPS=12.71 | Chg7d=-0.227 | Chg30d=-0.274 | Revisions Net=-4 | Growth EPS=+3.5% | Growth Revenue=+8.1%
EPS next Year (2028-01-31): EPS=13.73 | Chg7d=-0.247 | Chg30d=-0.288 | Revisions Net=-2 | Growth EPS=+8.0% | Growth Revenue=+3.5%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.0% (Discount Rate 8.5% - Earnings Yield 4.6%)
[Growth] Growth Spread = +5.8% (Analyst 9.8% - Implied 4.0%)
P/E Forward = 18.5185
P/S = 1.7188
P/B = 321.8177
P/EG = 2.1776
Revenue TTM = 86.29b USD
EBIT TTM = 9.85b USD
EBITDA TTM = 11.97b USD
Long Term Debt = 37.50b USD (from longTermDebt, two quarters ago)
Short Term Debt = 3.14b USD (from shortTermDebt, last quarter)
Debt = 7.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.21b USD (from netDebt column, last quarter)
Enterprise Value = 154.14b USD (148.31b + Debt 7.19b - CCE 1.35b)
Interest Coverage Ratio = 8.90 (Ebit TTM 9.85b / Interest Expense TTM 1.11b)
EV/FCF = 20.15x (Enterprise Value 154.14b / FCF TTM 7.65b)
FCF Yield = 4.96% (FCF TTM 7.65b / Enterprise Value 154.14b)
FCF Margin = 8.87% (FCF TTM 7.65b / Revenue TTM 86.29b)
Net Margin = 7.71% (Net Income TTM 6.65b / Revenue TTM 86.29b)
Gross Margin = 33.48% ((Revenue TTM 86.29b - Cost of Revenue TTM 57.40b) / Revenue TTM)
Gross Margin QoQ = 39.16% (prev 31.91%)
Tobins Q-Ratio = 2.85 (Enterprise Value 154.14b / Total Assets 54.14b)
Interest Expense / Debt = 5.45% (Interest Expense 392.0m / Debt 7.19b)
Taxrate = 23.45% (306.0m / 1.30b)
NOPAT = 7.54b (EBIT 9.85b * (1 - 23.45%))
Current Ratio = 1.08 (Total Current Assets 20.95b / Total Current Liabilities 19.46b)
Debt / Equity = -0.72 (negative equity) (Debt 7.19b / totalStockholderEquity, last quarter -9.92b)
Debt / EBITDA = 0.52 (Net Debt 6.21b / EBITDA 11.97b)
Debt / FCF = 0.81 (Net Debt 6.21b / FCF TTM 7.65b)
Total Stockholder Equity = -11.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.48% (Net Income 6.65b / Total Assets 54.14b)
RoE = -59.21% (negative equity) (Net Income TTM 6.65b / Total Stockholder Equity -11.24b)
RoCE = 37.53% (EBIT 9.85b / Capital Employed (Equity -11.24b + L.T.Debt 37.50b))
RoIC = 30.44% (NOPAT 7.54b / Invested Capital 24.78b)
WACC = 8.33% (E(148.31b)/V(155.50b) * Re(8.53%) + D(7.19b)/V(155.50b) * Rd(5.45%) * (1-Tc(0.23)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.53%
[DCF] Terminal Value 76.35% ; FCFF base≈7.67b ; Y1≈7.41b ; Y5≈7.32b
[DCF] Fair Price = 206.0 (EV 121.78b - Net Debt 6.21b = Equity 115.58b / Shares 561.0m; r=8.33% [WACC]; 5y FCF grow -4.62% → 2.90% )
EPS Correlation: -31.47 | EPS CAGR: -14.16% | SUE: -1.45 | # QB: 0
Revenue Correlation: -52.18 | Revenue CAGR: -3.64% | SUE: 1.14 | # QB: 1
EPS next Quarter (2026-04-30): EPS=2.99 | Chg7d=-0.093 | Chg30d=-0.087 | Revisions Net=-1 | Analysts=26
EPS current Year (2027-01-31): EPS=12.71 | Chg7d=-0.227 | Chg30d=-0.274 | Revisions Net=-4 | Growth EPS=+3.5% | Growth Revenue=+8.1%
EPS next Year (2028-01-31): EPS=13.73 | Chg7d=-0.247 | Chg30d=-0.288 | Revisions Net=-2 | Growth EPS=+8.0% | Growth Revenue=+3.5%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.0% (Discount Rate 8.5% - Earnings Yield 4.6%)
[Growth] Growth Spread = +5.8% (Analyst 9.8% - Implied 4.0%)